StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) stock

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$294.55−0.48 (-0.16%)

Close on Nov 16, 2026Market cap $520.50BP/E 83.2Yield 2.26%

AbbVie profit margin

Profit margin (net margin) is net income as a percentage of revenue.

AbbVie's profit margin for the twelve months ending Jun 30, 2026 was 9.8%. For fiscal 2025 it was 6.9%, against 7.6% the year before. The highest annual figure on record is 23.7% in fiscal 2019.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20256.9%−0.7
FY2024Dec 31, 20247.6%−1.4
FY2023Dec 31, 20239.0%−11.4
FY2022Dec 31, 202220.4%−0.2
FY2021Dec 31, 202120.5%+10.5
FY2020Dec 31, 202010.1%−13.6
FY2019Dec 31, 201923.7%+6.3
FY2018Dec 31, 201817.4%−1.5
FY2017Dec 31, 201718.8%−4.4
FY2016Dec 31, 201623.2%+0.7
FY2015Dec 31, 201522.5%+13.6
FY2014Dec 31, 20148.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202621.3%+15.2
Q1 FY2026Mar 31, 20264.6%−5.0
Q4 FY2025Dec 31, 202510.9%+11.1
Q3 FY2025Sep 30, 20251.2%−9.6
Q2 FY2025Jun 30, 20256.1%−3.4
Q1 FY2025Mar 31, 20259.6%−1.5
Q4 FY2024Dec 31, 2024-0.1%−5.9
Q3 FY2024Sep 30, 202410.8%−2.0
Q2 FY2024Jun 30, 20249.5%−5.1
Q1 FY2024Mar 31, 202411.1%+9.2
Q4 FY2023Dec 31, 20235.7%−10.6
Q3 FY2023Sep 30, 202312.8%−13.9
Q2 FY2023Jun 30, 202314.6%+8.3
Q1 FY2023Mar 31, 20232.0%−31.2
Q4 FY2022Dec 31, 202216.4%−10.8
Q3 FY2022Sep 30, 202226.7%+4.5
Q2 FY2022Jun 30, 20226.3%+0.8
Q1 FY2022Mar 31, 202233.2%+5.9
Q4 FY2021Dec 31, 202127.2%+26.9
Q3 FY2021Sep 30, 202122.2%+4.3
Q2 FY2021Jun 30, 20215.5%+12.6
Q1 FY2021Mar 31, 202127.3%−7.6
Q4 FY2020Dec 31, 20200.3%−31.9
Q3 FY2020Sep 30, 202017.9%−4.3
Q2 FY2020Jun 30, 2020-7.1%−16.1
Q1 FY2020Mar 31, 202034.9%+3.5
Q4 FY2019Dec 31, 201932.2%+54.2
Q3 FY2019Sep 30, 201922.2%−11.1
Q2 FY2019Jun 30, 20199.0%−15.0
Q1 FY2019Mar 31, 201931.4%−3.7
Q4 FY2018Dec 31, 2018-22.0%−22.7
Q3 FY2018Sep 30, 201833.4%+10.0
Q2 FY2018Jun 30, 201824.0%−3.6
Q1 FY2018Mar 31, 201835.1%+8.9
Q4 FY2017Dec 31, 20170.7%−19.8
Q3 FY2017Sep 30, 201723.3%−1.5
Q2 FY2017Jun 30, 201727.6%–
Q1 FY2017Mar 31, 201726.2%–
Q4 FY2016Dec 31, 201620.5%–
Q3 FY2016Sep 30, 201624.8%–

More AbbVie figures

See a number that looks wrong?